Table 1

Perception of target groups for and practice of pneumococcal immunisation

Pneumococcal immunisation is recommended by the DOH for:Yes (%)No (%)No answer (%)
Adults living in residential or nursing homes17 (30.3)31 (55.3)8 (14.4)
All children under 5 years1 (1.7)46 (82.1)9 (16.2)
All adults over 65 years of age7 (12.5)40 (71.4)9 (16.1)
All adult diabetic patients1-150 35 (62.5)15 (26.8)6 (10.7)
All adult patients with chronic heart or lung disease1-150 43 (76.8)8 (14.3)5 (8.9)
Patients over two years old with chronic renal disease1-150 43 (76.8)6 (10.7)7 (12.5)
Adult patients with hyposplenism from whatever cause1-150 53 (94.6)1 (1.7)2 (3.7)
Adults with HIV infection1-150 37 (66.1)11 (19.6)8 (14.3)
All adults with previous pneumococcal meningitis6 (10.7)37 (66.1)13 (23.2)
Contacts of cases of pneumococcal meningitis11 (19.6)33 (58.9)12 (21.5)
Travellers to areas with a high incidence of pneumonia5 (8.9)40 (71.4)11 (19.7)
Adult patients receiving immunosuppressive drugs1-150 35 (62.5)12 (21.4)9 (16.1)
For which of the following groups is it your current practice to carry out pneumococcal immunisation?
Splenectomy1-150 52 (92.8)0 (0)4 (7.2)
Hyposplenism from sickle cell disease1-150 48 (85.7)2 (3.6)6 (10.7)
Hyposplenism from other causes, for example, coeliac disease1-150 36 (64.2)11 (19.6)9 (16.2)
Chronic renal disease or nephrotic syndrome1-150 32 (57.1)15 (26.7)9 (16.2)
Chronic heart disease1-150 21 (37.5)25 (44.6)10 (17.9)
Chronic lung disease1-150 21 (37.5)24 (42.8)11 (19.7)
Chronic liver disease including cirrhosis1-150 19 (33.9)27 (48.2)10 (17.9)
Adult diabetic patients1-150 20 (35.7)26 (46.4)10 (17.9)
  • 1-150 Patient group recommended for immunisation by the UK Department of Health.